Financial Insights’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Buy
817
+34
+4% +$34.7K 0.26% 58
2026
Q1
$720K Buy
783
+94
+14% +$95.3K 0.23% 61
2025
Q4
$740K Sell
689
-46
-6% -$44K 0.25% 58
2025
Q3
$561K Buy
735
+157
+27% +$117K 0.19% 65
2025
Q2
$451K Sell
578
-25
-4% -$19.4K 0.16% 73
2025
Q1
$498K Buy
+603
New +$502K 0.2% 63
2024
Q4
– Sell
-250
Closed -$221K – 130
2024
Q3
$221K Sell
250
-49
-16% -$44.1K 0.07% 138
2024
Q2
$271K Hold
299
– – 0.08% 137
2024
Q1
$233K Buy
+299
New +$213K 0.06% 152
2021
Q3
– Sell
-155
Closed -$35.6K – 164
2021
Q2
$35.6K Buy
+155
New +$31.1K 0.03% 194

Other funds holding LLY

Financial Insights's LLY Position: Q2 2026 in Review

Financial Insights increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $34.7K and bringing the position to 817 shares worth $980K. The position accounts for 0.26% of the portfolio, ranked #58.

Financial Insights first reported a position in LLY in Q2 2021 and has held it in 10 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Financial Insights held 817 shares of Eli Lilly worth $980K as of Q2 2026.
  • Financial Insights bought 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 0.26% of Financial Insights's portfolio in Q2 2026, its #58 holding.
  • Financial Insights first reported a position in Eli Lilly in Q2 2021 and has held it in 10 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Financial Insights's 13F filing for Q2 2026, filed 25 Aug 2026.